Sysmex : Information about Termination of the Litigation against Sysmex Corporation and its Subsidiary (PDF:128KB)
January 11, 2022 at 01:18 am EST
Share
January 11, 2022
Sysmex Corporation
Information about Termination of the Litigation against Sysmex Corporation
and its Subsidiary
Sysmex Corporation and its US subsidiary Sysmex America, Inc. (hereinafter referred to as "SAI" and Sysmex Corporation and SAI hereinafter collectively referred to as "Sysmex") have addressed the lawsuit (hereinafter referred to as the "Lawsuit") brought by Uniface B.V. (current Rocket Software B.V., hereinafter referred to as the "Plaintiff") in Belgium. Sysmex Corporation hereby announces with the details described as below that the Plaintiff and Sysmex have reached settlement agreement and the Lawsuit will be terminated by the Plaintiff's withdrawal.
Background from filing of the Lawsuit to settlement
In April 2020, the Plaintiff summoned Sysmex before the Dutch-Speaking Enterprise Court of Brussels, Belgium. The plaintiff alleged that Sysmex breached a software license agreement (hereinafter referred to as the "Agreement"; the Agreement was terminated in January 2020) executed in 2002 between Sysmex Corporation and Compuware N.V. (hereinafter referred to as "Compuware"; the Plaintiff acquired Compuware assets, including the Agreement, in 2014). On August 23, 2021 (Central European Time), the Dutch-Speaking Enterprise Court of Brussels, Belgium rendered a judgment and the Plaintiff has filed an appeal against this judgment to the Court of Appeal of Brussels, Belgium on November 8, 2021 (Central European Time).
While proceeding with the Lawsuit, the Plaintiff and Sysmex had discussions for a settlement and a settlement has been reached.
Overview of counterparty to settlement
Name: Rocket Software B.V.
Registered Office: Dordrecht, Netherlands
Details of the settlement
The Plaintiff and SAI have entered into a new license agreement under which the Plaintiff provides SAI with a software license for maintenance support to its customers for a certain period of time, and SAI pays a certain amount as the consideration to the Plaintiff. Also, based on the settlement, the Plaintiff will withdraw the Lawsuit and all the other claims against Sysmex related to the Lawsuit.
Future outlook
Based upon the settlement, the Plaintiff will proceed with the withdrawal of the Lawsuit and the Lawsuit will be terminated upon completion of required court procedures.
The termination of the Lawsuit based upon the settlement has no significant financial impact for Sysmex.
(Reference) Consolidated financial results forecasts for the current fiscal year (released on November
10, 2021) and actual consolidated results for the previous fiscal year
(Millions of yen)
Net sales
Operating profit
Profit before tax
Profit attributable to
owners of the parent
Consolidated financial
results forecasts for the
current fiscal year
360,000
66,000
63,000
44,000
(Fiscal year ending
March 31, 2022)
Actual consolidated
results for the previous
fiscal year
305,073
51,792
48,033
33,142
(Fiscal year ended
March 31, 2021)
Attachments
Original Link
Original Document
Permalink
Disclaimer
Sysmex Corporation published this content on 11 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 January 2022 06:17:15 UTC.
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.